Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JIE YANG

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1386719060
CMS profile
334777
Location
NORWICH, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$3,452.05

176 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,283.32 174
Education $168.73 2

By paying entity

PY2024 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 176 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JIE YANG

NPI 1386719060 · CMS profile ID 334777

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

NORWICH, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 176 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1386719060?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JIE YANG, NPI 1386719060, CMS profile ID 334777. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 176 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1386719060?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). JIE YANG, NPI 1386719060, CMS profile ID 334777. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 176 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1386719060?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
JIE YANG, NPI 1386719060, CMS profile ID 334777, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 176 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1386719060?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

176 matching records · $3,452.05 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 176 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 176.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme LLC $21.0606/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141672697 CMS
ABBVIE INC. $15.4905/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106370400 CMS
Novartis Pharmaceuticals Corporation $13.7005/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087346104 CMS
GENZYME CORPORATION $17.0705/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139706881 CMS
AstraZeneca Pharmaceuticals LP $22.7805/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104634767 CMS
Genentech USA, Inc. $20.4505/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133032873 CMS
JAZZ PHARMACEUTICALS INC. $13.5105/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150212561 CMS
Rigel Pharmaceuticals, Inc. $27.0205/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145199443 CMS
AstraZeneca Pharmaceuticals LP $19.5105/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105851152 CMS
Blueprint Medicines Corporation $34.7305/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147452109 CMS
SOBI, INC $15.3805/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141422355 CMS
ADC Therapeutics America, Inc. $23.6305/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1121188184 CMS
Janssen Biotech, Inc. $16.8905/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078383294 CMS
Novartis Pharmaceuticals Corporation $14.5005/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087346100 CMS
ARRAY BIOPHARMA INC $21.8005/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1130927353 CMS
Acrotech Biopharma Inc. $27.4504/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147106482 CMS
Merck Sharp & Dohme LLC $16.6504/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141672699 CMS
Mirati Therapeutics, Inc. $14.8304/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117175006 CMS
Eisai Inc. $18.8004/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110752792 CMS
ADC Therapeutics America, Inc. $19.6904/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1121188180 CMS
AstraZeneca Pharmaceuticals LP $7.5404/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105746549 CMS
Novartis Pharmaceuticals Corporation $8.1904/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087346098 CMS
Astellas Pharma US Inc $23.9804/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139334186 CMS
Celgene Corporation $18.1804/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101173442 CMS
Janssen Biotech, Inc. $20.2104/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078383680 CMS
Genentech USA, Inc. $20.0704/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133032881 CMS
PFIZER INC. $17.1704/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131302991 CMS
GENZYME CORPORATION $17.2204/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139706865 CMS
Lilly USA, LLC $15.9604/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135066869 CMS
Astellas Pharma US Inc $17.1304/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139302778 CMS
Rigel Pharmaceuticals, Inc. $24.7304/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145199417 CMS
Novartis Pharmaceuticals Corporation $23.2604/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087346096 CMS
Regeneron Healthcare Solutions, Inc. $32.5904/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114258372 CMS
Alexion Pharmaceuticals, Inc. $19.4703/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093925168 CMS
GlaxoSmithKline, LLC. $23.0603/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116209768 CMS
PFIZER INC. $17.5003/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1130927049 CMS
Incyte Corporation $14.5003/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141187308 CMS
Rigel Pharmaceuticals, Inc. $10.0203/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145199415 CMS
Rigel Pharmaceuticals, Inc. $17.3003/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145201606 CMS
Celgene Corporation $18.0403/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101173440 CMS
Novartis Pharmaceuticals Corporation $22.4103/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087346094 CMS
Merck Sharp & Dohme LLC $24.9403/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141672693 CMS
Janssen Biotech, Inc. $26.9703/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078383610 CMS
Novartis Pharmaceuticals Corporation $15.2803/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087346092 CMS
GENZYME CORPORATION $21.7102/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139706843 CMS
Eisai Inc. $18.3002/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110752794 CMS
AstraZeneca Pharmaceuticals LP $20.7202/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104223973 CMS
Aveo Pharmaceuticals, Inc. $28.9002/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143479696 CMS
Rigel Pharmaceuticals, Inc. $5.0602/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145199413 CMS
Rigel Pharmaceuticals, Inc. $19.8702/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145201604 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,086.52 142
PY2020 $1,303.42 81
PY2021 $2,086.75 118
PY2022 $2,734.64 141
PY2023 $2,854.51 145
PY2024 $3,452.05 176
PY2025 $3,541.83 163

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $11,268.90 9
PY2023 Principal investigator $39,405.03 4
PY2022 Principal investigator $236,638.07 7
PY2021 Recipient $500.05 1
PY2021 Principal investigator $234,210.15 3
PY2020 Principal investigator $216,406.63 2
PY2019 Principal investigator $1,940.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Chiesi USA, Inc. $4,000.00 05/09/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148219534
Principal investigator 1 Chiesi USA, Inc. $1,800.00 05/09/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148219536
Principal investigator 1 Chiesi USA, Inc. $500.00 05/09/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148219538
Principal investigator 1 Chiesi USA, Inc. $747.70 03/07/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148216782
Principal investigator 1 Novartis Pharmaceuticals Corporation $752.00 02/29/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY & ONCOLOGY ASSOCIATES
Ribociclib Standard Endocrine therapy in patients with HR HER2 Early BC at High amp Intermediate Risk for Recurrence No dispute reported 06/30/2026 1089689717
Principal investigator 1 Genentech, Inc. $555.00 02/26/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY & ONCOLOGY ASSOCIATES PC
Chemo trastuzumab vs chemo trastuzumab pertuzumab No dispute reported 06/30/2026 1133392826
Principal investigator 1 Chiesi USA, Inc. $971.40 01/17/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148214631
Principal investigator 1 Chiesi USA, Inc. $971.40 01/17/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148214633
Principal investigator 1 Chiesi USA, Inc. $971.40 01/17/2024 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGYONCOLOGY ASSOCIATES
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use ofCUSA-081for Dysfunctional Central Venous Access Devices (CVADs) No dispute reported 06/30/2026 1148214635